Абсорбция След подкожно приложение на 240 mg дегареликс в концентрация 40 mg/ ml на пациенти с рак на простатата при основното проучване CS21, AUC0- 28 ден е 635 (602- 668) ден* ng/ ml, Cmax е 66, 0 (61, 0- 71, 0) ng/ ml и настъпва при tmax на 40 (37- 42) часа.
Absorption Following subcutaneous administration of 240 mg degarelix at a concentration of 40 mg/ ml to prostate cancer patients in the pivotal study CS21, AUC0-28 days was 635 (602-668) day*ng/ ml, Cmax was 66.0 (61.0-71.0) ng/ ml and occurred at tmax at 40 (37-42) hours.